HC Deb 04 February 2004 vol 417 c953W
Mrs. Iris Robinson

To ask the Secretary of State for Northern Ireland what additional funding was provided in 2003 for new specialist prescribed drugs for(a) rheumatoid arthritis and (b) multiple sclerosis. [150750]

Angela Smith

The additional £3 million allocated to Health and Social Services Boards in the 2002–03 financial year towards the costs of new specialist drug treatments including those for rheumatoid arthritis and multiple sclerosis has been made recurrent in the current financial year 2003–04 and increased to £3.1 million to cover inflation.

A further £100,000 made available in September 2002 specifically for infrastructure support for beta interferon treatment for multiple sclerosis has also been made recurrent thus relieving pressures elsewhere in these drugs budgets.